期刊文献+

抗心型脂肪酸结合蛋白单克隆抗体制备、鉴定和在侧向免疫层析方法中的应用 被引量:4

Development and Characterization of Monoclonal Antibodies Against Human Heart Type Fatty Acid Binding Protein and Its Application in Lateral Flow Immunoassay
原文传递
导出
摘要 目的:制备抗心型脂肪酸结合蛋白(H-FABP)单克隆抗体(mAb),并建立侧向免疫层析方法检测血浆中H-FABP。方法:用H-FABP蛋白免疫纯系Balb/c小鼠,采用杂交瘤技术建立能稳定分泌抗人H-FABP的单克隆杂交瘤细胞株。常规制备腹水,纯化后得到特异性抗H-FABP单克隆抗体,进行效价、特异性、亲和力的鉴定分析,并在ELISA平台进行抗体配对,用所筛选到的抗体对初步建立了检测H-FABP的侧向免疫层析方法。结果:成功获得12株稳定分泌抗体的阳性细胞株,并筛选出能相互配对,并应用于侧向免疫层析平台的抗体3D1和5F4,检测临床样品与对照试剂比较总符合率为100%。结论:筛选能稳定分泌抗体的细胞株,配对抗体应用于侧向免疫层析检测方法中,能快速、特异、灵敏的检测出临床样品中H-FABP,为临床应用快速检测H-FABP指标提供了方法和关键材料。 AIM: To develop and characterize monoclonal antibodies(mAb) against human heart type fatty acid binding protein(H-FABP);To develop a rapid lateral flow immunoassay for detecting H-FABP in plasma using the identified mAbs.Methods: BALB/c mice were immunized with H-FABP.The hybridoma cells were generated by fusing spleen cells and myeloma cells SP2/0 followed by screening and clonally selecting.The mAbs were purified from ascites and characterized by indirect ELISA and Western Blot,and were used for developing a rapid lateral flow immunoassay.Results: Twelve hybridoma cell lines were found to secret anti-H-FABP with high titers,specificity and affinity.Among them,the antibody pair of 3D1 and 5F4 were used as conjugate and coating antibody,respectively,in lateral flow immunoassay.The newly developed assay was used to detect 203 patients plasma.A 100% consistence was observed when compared with the reference kit.Conclusion: Two mAbs against H-FABP with high titers,specificity and affinity were obtained.The rapid lateral flow immunoassay was successfully developed for sensitive and specific detection of H-FABP in human plasma by using these mAbs.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2013年第1期72-78,共7页 China Biotechnology
基金 卫生部<重组蛋白和抗体库研制平台>资助项目(2011ZX09506-001)
关键词 H-FABP 单克隆抗体 POCT 免疫层析 H-FABP Monoclonal antibody Point of care testing Lateral flow immunoassay
  • 相关文献

参考文献15

  • 1Ockner R K,Manning J A,Poppenhausen R B. A bindingprotein for fatty acids in cytosol of intestinal mucosa,liver,myocardium,and other tissues[J].Science,1972,(4043):56-58.
  • 2Su A I,Wiltshire T,Batalov S. A geneatlas of the mouse and human protein-encodingtranscriptomes[J].Proceedings of the National Academy of Sciences(USA),2004,(16):6062-6067.doi:10.1073/pnas.0400782101.
  • 3Schaap F G,Binas B,Danneberg H. Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene[J].Circulation Research,1999,(04):329-337.
  • 4Tanaka T,Hirota Y,Sohmiya K. Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction[J].Clinical Biochemistry,1991,(02):195-201.
  • 5Pelsers M M,Hermens W T,Glatz J F. Fatty acid-binding proteins asplasma markers of tissue injury[J].Clinica Chimica Acta,2005,(1-2):15-35.
  • 6Chan C P,Sanderson J E,Glatz J F. A superior early myocardial infarction marker.Human heart-type fatty acid-binding protein[J].Zeitschrift für Kardiologie,2004,(05):388-397.
  • 7Bertinchant J P,Polge A. Diagnostic and prognostic value of heart-type fatty acid-binding protein (H-FABP),an early biochemical marker of myocardial injury[J].Archives Des Maladies Du Coeur Et Des Vaisseaux,2005,(12):1225-1231.
  • 8Alhadi H A,Fox K A. Do we need additional markers of myocytenecrosis:the potential value of heart fatty-acid-binding protein[J].Quarterly Journal of Medicine,2004,(04):187-198.
  • 9Raghava G P,Agrewala J N. Method for determining the affinity of monoclonal antibody using non-competitive ELISA:a computer program[J].Journal of Immunoassay,1994,(02):115-128.
  • 10Ghani F,Wu A H,Graff L. Role of heart-type fatty acid-binding protein in early detection of acute myocardial infarction[J].Clinical Chemistry,2000,(05):718-719.

同被引文献64

  • 1张文平,钟有添,王小丽.实验教学中双向琼脂扩散法的改进[J].赣南医学院学报,2005,25(2):283-284. 被引量:2
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2143
  • 3Chutipongtanate S, Wateharatanyatip K, Homvises T, et al. Sys- tematic comparisons of various spectrophotometric and colorimetric methods to measure concentrations of protein, peptide and amino acid: detectable limits, linear dynamic ranges, interferences, prac- ticality and unit costs[J]. Talanta,2012,98(30) 123-129.
  • 4Tzamaloukas AH, Konstantinov KN, Agaba EI, et al. Twenty- first Century ethics of medical research involving human subjects: achievements and challenges[J]. Int Urol Nephrol, 2008,40 ( 1 ) .. 153-163.
  • 5Elvin JG, Couston RG, van der Walle CF. Therapeutic antibodies: market considerations, disease targets and bioprocessing[J]. Int J Pharm,2013, 440(1): 83-98.
  • 6Tapia VE, Ay B, Volkmer R. Exploring and profiling protein function with peptide arrays[J]. Methods Mol Biot, 2009,570(8): 3-17.
  • 7府伟灵,徐克前.临床生物化学检验[M].5版.北京:人民卫生出版社,2011:66-68.
  • 8Reibis R, Voller H, Gitt A et al. Management of patients with ST-segment elevation or non-ST-segment elevation acute coronary syndromes in cardiac rehabilitation centers [J]. Clin Cardiol, 2014, 37(4): 213-221.
  • 9Meier P, Lansky A J, Baumbach A. Almanac 2013: acute coronary syndromes [J]. Acta Cardiol, 2014, 69(1): 100-108.
  • 10National Committee for Clinical Laboratory Standards. method comparison and bias estimation using patient samples EP09-A2 [J]. Clin Laborat Stand Instit, 2002, 22(19):1-52.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部